Role of human and mouse HspB1 in metastasis

Current Molecular Medicine

Volumn 12, Issue 9, 2012, Pages 1142-1150

  Nagaraja, G M ^a   Kaur, P ^a   Asea, A ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cancer; CD+ CTL; Heat shock proteins; Lentivirus; Metastasis; siRNA

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ALPHA CRYSTALLIN; ANTINEOPLASTIC AGENT; HEAT SHOCK PROTEIN 27; MATRIX METALLOPROTEINASE; OGX 0427; RP 101; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; FIBROBLAST; GENE SILENCING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY CARCINOMA; LEUKOCYTE; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MACROPHAGE; MASS SPECTROMETRY; MELANOMA; METASTASIS; MOLECULAR WEIGHT; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; STOMACH CANCER; TUMOR CELL; UPREGULATION; WESTERN BLOTTING;

AGING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN FOLDING; REACTIVE OXYGEN SPECIES;

EID: 84867782766     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412803306701     Document Type: Review

References (85)

1. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602.
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72.
3. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990; 54: 159-211.
4. Wong CW, Lee A, Shientag L, et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res 2001; 61: 333-8.
5. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
6. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
7. Edlund M, Sung SY, Chung LW. Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem 2004; 91: 686-705.
8. Triozzi PL, Eng C, Singh AD. Targeted therapy for uveal melanoma. Cancer Treat Rev 2008; 34: 247-58.
9. Wang W, Mouneimne G, Sidani M, et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006; 173: 395-404.
10. Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 2000; 60: 2504-11.
11. Wood S, Jr. Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. AMA Arch Pathol 1958; 66: 550-68.
12. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-74.
13. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005; 15: 87-96.
14. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64: 7022-9.
15. Wyckoff JB, Wang Y, Lin EY, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007; 67: 2649-56.
16. Li CY, Shan S, Huang Q, et al. Initial stages of tumor cellinduced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst 2000; 92: 143-7.
17. Sahai E, Garcia-Medina R, Pouyssegur J, Vial E. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol 2007; 176: 35-42.
18. Dadiani M, Kalchenko V, Yosepovich A, et al. Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res 2006; 66: 8037-41.
19. Hoshida T, Isaka N, Hagendoorn J, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006; 66: 8065-75.
20. Hagendoorn J, Tong R, Fukumura D, et al. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res 2006; 66: 3360-4.
21. Im JH, Fu W, Wang H, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 2004; 64: 8613-9.
22. Wang H, Fu W, Im JH, et al. Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004; 164: 935-41.
23. Tsuji K, Yamauchi K, Yang M, et al. Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area. Cancer Res 2006; 66: 303-6.
24. Paul C, Simon S, Gibert B, et al. Dynamic processes that reflect anti-apoptotic strategies set up by HspB1 (Hsp27). Exp Cell Res 2010; 316: 1535-52.
25. de Jong WW, Caspers GJ, Leunissen JA. Genealogy of the alpha-crystallin--small heat-shock protein superfamily. Int J Biol Macromol 1998; 22: 151-62.
26. Plesofsky-Vig N, Vig J, Brambl R. Phylogeny of the alphacrystallin-related heat-shock proteins. J Mol Evol 1992; 35: 537-45.
27. Frohli E, Aoyama A, Klemenz R. Cloning of the mouse hsp25 gene and an extremely conserved hsp25 pseudogene. Gene 1993; 128: 273-7.
28. Knauf U, Jakob U, Engel K, et al. Stress- and mitogeninduced phosphorylation of the small heat shock protein Hsp25 by MAPKAP kinase 2 is not essential for chaperone properties and cellular thermoresistance. Embo J 1994; 13: 54-60.
29. Landry J, Chretien P, Lambert H, et al. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 1989; 109: 7-15.
30. Nover L, Scharf KD, Neumann D. Formation of cytoplasmic heat shock granules in tomato cell cultures and leaves. Mol Cell Biol 1983; 3: 1648-55.
31. Miron T, Vancompernolle K, Vandekerckhove J, et al. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol 1991; 114: 255-61.
32. Nicholl ID, Quinlan RA. Chaperone activity of alphacrystallins modulates intermediate filament assembly. Embo J 1994; 13: 945-53.
33. Lavoie JN, Hickey E, Weber LA, Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 1993; 268: 24210-4.
34. Arrigo AP. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 1998; 379: 19-26.
35. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 1996; 271: 16510-4.
36. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
37. Hoa M, Davis SL, Ames SJ, Spanjaard RA. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res 2002; 62: 7154-6.
38. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-6000.
39. Beder LB, Gunduz M, Ouchida M, et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003; 83: 99-105.
40. Zhu Z, Xu X, Yu Y, et al. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharm 2010; 7: 1283-90.
41. Gandour-Edwards R, Trock BJ, Gumerlock P, Donald PJ. Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 1998; 118: 610-5.
42. Lo Muzio L, Leonardi R, Mariggio MA, et al. HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol 2004; 19: 119-28.
43. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994; 39: 93-8.
44. Srivastava PK, Heike M. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin Immunol 1991; 3: 57-64.
45. Kawanishi K, Shiozaki H, Doki Y, et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999; 85: 1649-57.
46. Kang SH, Kang KW, Kim KH, et al. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer 2008; 8: 286.
47. Li DQ, Wang L, Fei F, et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006; 6: 3352-8.
48. Garrido C, Fromentin A, Bonnotte B, et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 1998; 58: 5495-9.
49. Vargas-Roig LM, Gago FE, Tello O, et al. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998; 79: 468-75.
50. Lemieux P, Oesterreich S, Lawrence JA, et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 1997; 17: 113-23.
51. Bausero MA, Page DT, Osinaga E, Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol 2004; 25: 243-51.
52. Bausero MA, Bharti A, Page DT, et al. Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol 2006; 27: 17-26.
53. Nagaraja GM, Kaur P, Newmann W, et al. Silencing hsp25 geneexpression augments proteasome activity and increases CD8+ t-cell mediated memory and tumor killing. Cancer Prev Res 2012; 5(1): 122-37.
54. Kaur P, Nagaraja GM, Asea A. Combined lentiviral and RNAi technologies for the delivery and permanent silencing of the hsp25 gene. Methods Mol Biol 2011; 787: 121-36.
55. Groettrup M, Soza A, Eggers M, et al. A role for the proteasome regulator PA28alpha in antigen presentation. Nature 1996; 381: 166-8.
56. Sun Y, Sijts AJ, Song M, et al. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res 2002; 62: 2875-82.
57. Andrieu C, Taieb D, Baylot V, et al. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene 2010; 29: 1883-96.
58. Trott D, McManus CA, Martin JL, et al. Effect of phosphorylated hsp27 on proliferation of human endothelial and smooth muscle cells. Proteomics 2009; 9: 3383-94.
59. Knapinska AM, Gratacos FM, Krause CD, et al. Chaperone Hsp27 modulates AUF1 proteolysis and AU-rich elementmediated mRNA degradation. Mol Cell Biol 2011; 31: 1419-31.
60. Chang E, Heo KS, Woo CH, et al. MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation. Blood 2011; 117: 2527-37.
61. de Thonel A, Vandekerckhove J, Lanneau D, et al. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood 2010; 116: 85-96.
62. + T cell-mediated tumor killing and memory responses. Cancer Prev Res (Phila) 2012; 5: 122-37.
63. Markowitz SD, Dawson DM, Willis J, Willson JK. Focus on colon cancer. Cancer Cell 2002; 1: 233-6.
64. Ehrenfried JA, Herron BE, Townsend CM, Jr., Evers BM. Heat shock proteins are differentially expressed in human gastrointestinal cancers. Surg Oncol 1995; 4: 197-203.
65. Yu Z, Zhi J, Peng X, et al. Clinical significance of HSP27 expression in colorectal cancer. Molecular medicine reports 2010; 3: 953-8.
66. Zhao L, Li ZG, Ding YQ. [Expression of HSP27 in colorectal carcinoma and its relationship with lymphatic metastasis]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2008; 28: 41-4.
67. Aldrian S, Trautinger F, Frohlich I, et al. Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 2002; 7: 177-85.
68. Song P, Bao H, Yu Y, et al. Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials. Proteomics Clin Appl 2009; 3: 841-52.
69. Guo K, Kang NX, Li Y, et al. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 2009; 9: 100.
70. Song HY, Liu YK, Feng JT, et al. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2006; 132: 92-98.
71. Chen J, Kahne T, Rocken C, et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 2004; 3: 1009-16.
72. Huang Q, Ye J, Chen W, et al. Heat shock protein 27 is overexpressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 2010; 48: 263-9.
73. Giaginis C, Daskalopoulou SS, Vgenopoulou S, et al. Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol 2009; 9: 14.
74. Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int 2001; 88: 818-24.
75. Erkizan O, Kirkali G, Yorukoglu K, Kirkali Z. Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology 2004; 64: 474-8.
76. Sarto C, Valsecchi C, Magni F, et al. Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 2004; 4: 2252-60.
77. Takashi M, Sakata T, Ohmura M, Kato K. Elevated concentrations of the small stress protein HSP27 in rat renal tumors. Urol Res 1997; 25: 173-7.
78. Kaur P, Hurwitz MD, Krishnan S, Asea A. Combined hyperthermia and radiotherapy for the eradication of cancer. Cancers 2011; 3: 3799-823.
79. Hadchity E, Aloy MT, Paulin C, et al. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther 2009; 17: 1387-94.
80. Hadaschik BA, Jackson J, Fazli L, et al. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. BJU Int 2008; 102: 610-6.
81. Aloy MT, Hadchity E, Bionda C, et al. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys 2008; 70: 543-53.
82. Rocchi P, Jugpal P, So A, et al. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. BJU Int 2006; 98: 1082-9.
83. Heinrich JC, Tuukkanen A, Schroeder M, et al. RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients. J Cancer Res Clin Oncol 2011; 137: 1349-61.
84. Kim EH, Lee HJ, Lee DH, et al. Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. Cancer Res 2007; 67: 6333-41.
85. Gibert B, Hadchity E, Czekalla A, et al. Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers. Oncogene 2011; 30: 3672-81.